ACSL4 coordinates metabolic and cell cycle reprogramming to promote endometrial cancer progression
Cellular Signalling · 2026
DOI: 10.1016/j.cellsig.2025.112255 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2026. Verfasst von Hongtao Guo und 6 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu 730000, China; Department of Obstetrics and Gynecology, the First Hospital of …. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Coenzyme A Ligases, Cell Cycle. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Lanzhou University First Hospital, Gansu Provincial Natural Science Foundation, Lanzhou University.
Abstract (Originalsprache)
Endometrial cancer (EC) is a common gynecologic malignancy associated with lipid metabolic reprogramming. We identified ACSL4, a fatty acid-activating enzyme, as significantly upregulated in EC and inversely correlated with tumor differentiation. Functional assays revealed that ACSL4 promotes EC cell proliferation, migration, and G1/S progression, while its knockdown exerts suppressive effects. Mechanistically, ACSL4 activates the PPARα-CPT1C axis to enhance fatty acid β-oxidation and upregulates E2F2 to drive cell cycle progression. Inhibition of ACSL4 with PRGL493 suppressed tumor growth in vitro and in vivo. These findings highlight ACSL4 as a dual regulator of lipid metabolism and cell proliferation and a potential therapeutic target in EC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu 730000, China; Department of Obstetrics and Gynecology, the First Hospital of Lanzhou University, Gansu Provincial Clinical Research Center for Gyne…
- The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu 730000, China.
- Department of Obstetrics and Gynecology, the First Hospital of Lanzhou University, Gansu Provincial Clinical Research Center for Gynecological Oncology, Branch of National Clinical Research Center for Gynecology and Obs…
Förderung
- Lanzhou University First Hospital
- Gansu Provincial Natural Science Foundation
- Lanzhou University
Zitieren
APA
Guo, H., Ma, Y., Ma, L., Liang, X., Li, H., Liu, C., & Yang, Y. (2026). ACSL4 coordinates metabolic and cell cycle reprogramming to promote endometrial cancer progression. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2025.112255
Vancouver
Guo H, Ma Y, Ma L, Liang X, Li H, Liu C, et al. ACSL4 coordinates metabolic and cell cycle reprogramming to promote endometrial cancer progression. Cellular Signalling. 2026. doi:10.1016/j.cellsig.2025.112255
BibTeX
@article{Guo2026,
author = {Guo, Hongtao and Ma, Yitong and Ma, Liangjian and Liang, Xiaolei and Li, Hongli and Liu, Chang and Yang, Yongxiu},
title = {ACSL4 coordinates metabolic and cell cycle reprogramming to promote endometrial cancer progression},
journal = {Cellular Signalling},
year = {2026},
doi = {10.1016/j.cellsig.2025.112255}
}
EUVIMED